Indian Pharma Network (IPN)
Medicines For Lung Cancer Treatment
IPN, New Delhi can facilitate Lymphoma patient to “import of Medicines For Lymphoma Treatment” for personal use under “patient name basis” treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.
Indian Pharma Network
M: +91-9891296838 / 9811747774
Lymphoma Cancer Treatment
Lymphoma is a type of cancer that starts in the lymphatic system, which is a part of the immune system that helps fight infections. There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment for lymphoma depends on the type and stage of the cancer, as well as other factors such as the patient’s age and overall health. Common treatments for lymphoma include chemotherapy, radiation therapy, targeted therapy, and immunotherapy.
Get Access FDA Approved Medicines For Lymphoma Treatment
The specific chemotherapy medicines used for lymphoma treatment depend on the type and stage of the cancer. Common chemotherapy drugs used for lymphoma treatment include:
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Methotrexate, Etoposide, Bleomycin, Procarbazine, Chlorambucil.
These drugs are often used in combination as part of a chemotherapy regimen. The specific regimen will depend on the individual patient’s case, including the type and stage of the cancer, as well as the patient’s age and overall health. The healthcare team will work to determine the best treatment plan for each individual patient based on their case and the current state of research in the field.
Targeted therapy medicines for lymphoma work by targeting specific molecules or pathways that are involved in the growth and spread of cancer cells. There are several targeted therapy drugs that may be used to treat lymphoma, including:
- Rituximab: This drug targets a protein called CD20 that is found on the surface of B cells, which are involved in the development of certain types of non-Hodgkin lymphoma.
- Brentuximab vedotin: This drug targets a protein called CD30, which is found on the surface of some types of lymphoma cells.
- Ibrutinib: This drug targets an enzyme called Bruton’s tyrosine kinase (BTK), which is involved in the development of some types of non-Hodgkin lymphoma.
- Venetoclax: This drug targets a protein called BCL-2, which is involved in the survival of some types of lymphoma cells.
- Pembrolizumab: This drug is a checkpoint inhibitor that targets a protein called PD-1, which is involved in the ability of cancer cells to evade the immune system.
Immunotherapy medicines can be used for the treatment of some types of lymphoma. These drugs work by boosting the immune system to help it recognize and attack cancer cells. The following are examples of immunotherapy drugs used for lymphoma treatment:
- Nivolumab: This drug is a checkpoint inhibitor that targets a protein called PD-1, which is involved in the ability of cancer cells to evade the immune system.
- Pembrolizumab: This drug is also a checkpoint inhibitor that targets PD-1.
- Ipilimumab: This drug targets a protein called CTLA-4, which is involved in the regulation of the immune system.
- Brentuximab vedotin: This drug, which is also a targeted therapy, can also be considered an immunotherapy drug, as it works by stimulating an immune response against cancer cells.
- CAR-T cell therapy: This is a type of immunotherapy in which a patient’s T cells are modified to target cancer cells. This involves collecting T cells from a patient, genetically modifying them to express chimeric antigen receptors (CARs) that recognize and attack cancer cells, and then infusing them back into the patient.
Radiation therapy uses high-energy beams of radiation to kill cancer cells. It may be used as the primary treatment for early-stage lymphoma or in combination with chemotherapy for more advanced stages. Radiation therapy is particularly effective in treating Hodgkin lymphoma, but may also be used for certain types of non-Hodgkin lymphoma.
The specific treatment plan for lymphoma will depend on the individual patient’s case, including the type and stage of the cancer, as well as the patient’s age and overall health. The healthcare team will work to determine the best treatment plan for each individual patient based on their case and the current state of research in the field.
Legitimate Healthcare Consultant and Facilitator In Delhi
If you have a question relating to anti-cancer medicines approved for treatment of Lymphoma, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email email@example.com as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
Query Form For Medications
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa